Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for American Well Corporation (AMWL : NYSE)

• Company Description    American Well Corp provides telehealth platform principally in the United States and globally. American Well Corp is based in BOSTON. Number of Employees: 877

• Price / Volume Information    Yesterday's Closing Price: $4.91 Daily Weekly Monthly 20 Day Moving Average: 130,388 shares Shares Outstanding: 16.37 (millions) Market Capitalization: $80.38 (millions) Beta: 1.26 52 Week High: $12.95 52 Week Low: $3.71 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 19.17% 19.38% 12 Week -20.81% -22.08% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 75 STATE STREET 26TH FLOOR - Boston,MA 02109 USA ph: 617-204-3500 fax: - investors@amwell.com https://business.amwell.com

• General Corporate Information    Officers Ido Schoenberg - Chief Executive Officer Mark Hirschhorn - Chief Financial Officer Paul McNeice - Chief Accounting Officer Roy Schoenberg - Director Rivka Goldwasser - Director Peer Information American Well Corporation (HLIS) American Well Corporation (AZTA) American Well Corporation (APYI) American Well Corporation (RNVA) American Well Corporation (HMSY) American Well Corporation (LRSI) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MEDICAL INFO SYS Sector: Medical CUSIP: 03044L204 SIC: 7389 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 02/11/26 Share - Related Items Shares Outstanding: 16.37 Most Recent Split Date: 7.00 (0.05:1) Beta: 1.26 Market Capitalization: $80.38 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-1.59 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-4.54 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 02/11/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.30 Price/Cash Flow: - Price / Sales: 0.30 EPS Growth vs. Year Ago Period: 39.37% vs. Previous Quarter: -40.32% Sales Growth vs. Year Ago Period: -7.80% vs. Previous Quarter: -20.61% ROE 12/31/25 - - 09/30/25 - -39.80 06/30/25 - -41.99 ROA 12/31/25 - - 09/30/25 - -29.38 06/30/25 - -30.80 Current Ratio 12/31/25 - - 09/30/25 - 3.14 06/30/25 - 3.29 Quick Ratio 12/31/25 - - 09/30/25 - 3.11 06/30/25 - 3.27 Operating Margin 12/31/25 - - 09/30/25 - -44.45 06/30/25 - -49.29 Net Margin 12/31/25 - - 09/30/25 - -42.80 06/30/25 - -46.15 Pre-Tax Margin 12/31/25 - - 09/30/25 - -41.34 06/30/25 - -45.36 Book Value 12/31/25 - - 09/30/25 - 16.33 06/30/25 - 18.24 Inventory Turnover 12/31/25 - - 09/30/25 - 53.69 06/30/25 - 44.65 Debt-to-Equity 12/31/25 - - 09/30/25 - 0.00 06/30/25 - 0.00 Debt-to-Capital 12/31/25 - - 09/30/25 - 0.00 06/30/25 - 0.00

Powered by Zacks Investment Research ©